1. Home
  2. APDN vs BGLC Comparison

APDN vs BGLC Comparison

Compare APDN & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APDN
  • BGLC
  • Stock Information
  • Founded
  • APDN 1983
  • BGLC 2017
  • Country
  • APDN United States
  • BGLC Malaysia
  • Employees
  • APDN N/A
  • BGLC N/A
  • Industry
  • APDN Other Consumer Services
  • BGLC Medical Specialities
  • Sector
  • APDN Consumer Discretionary
  • BGLC Health Care
  • Exchange
  • APDN Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • APDN 8.9M
  • BGLC 7.6M
  • IPO Year
  • APDN N/A
  • BGLC N/A
  • Fundamental
  • Price
  • APDN $0.23
  • BGLC $0.26
  • Analyst Decision
  • APDN Strong Buy
  • BGLC
  • Analyst Count
  • APDN 1
  • BGLC 0
  • Target Price
  • APDN $1.50
  • BGLC N/A
  • AVG Volume (30 Days)
  • APDN 8.7M
  • BGLC 1.5M
  • Earning Date
  • APDN 12-17-2024
  • BGLC 11-15-2024
  • Dividend Yield
  • APDN N/A
  • BGLC N/A
  • EPS Growth
  • APDN N/A
  • BGLC N/A
  • EPS
  • APDN N/A
  • BGLC N/A
  • Revenue
  • APDN $3,431,420.00
  • BGLC $9,259,858.00
  • Revenue This Year
  • APDN N/A
  • BGLC N/A
  • Revenue Next Year
  • APDN $48.01
  • BGLC N/A
  • P/E Ratio
  • APDN N/A
  • BGLC N/A
  • Revenue Growth
  • APDN N/A
  • BGLC N/A
  • 52 Week Low
  • APDN $0.12
  • BGLC $0.23
  • 52 Week High
  • APDN $14.40
  • BGLC $3.39
  • Technical
  • Relative Strength Index (RSI)
  • APDN 46.35
  • BGLC 40.08
  • Support Level
  • APDN $0.12
  • BGLC $0.25
  • Resistance Level
  • APDN $0.25
  • BGLC $0.28
  • Average True Range (ATR)
  • APDN 0.04
  • BGLC 0.05
  • MACD
  • APDN 0.01
  • BGLC 0.00
  • Stochastic Oscillator
  • APDN 51.62
  • BGLC 10.75

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Share on Social Networks: